Recent findings on the role of GPx4 in regulating ferroptosis, a type of cell death in response to excess lipid oxidation, suggest that suppression of GPx4 in atherogenesis and in some forms of cardiomyopathy may play a role in disease progression. Here, GPX4 is linked to cardiomyopathy.